To summarize, we show that JAK1 is a bona fide target of hsa-miR-127-3p and abnormal downregulation of renal hsa-miR-127-3p contributes to LN pathogenesis by enhancing the expression of JAK1 and the subsequent activation of IFN-I signaling pathway in kidney. Here, JAK1 is linked to lobular neoplasia.